Evaluation of Prognostic Monitoring for Breast Cancer Patients With Recurrence and Metastasis After Surgery
NCT04145973 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 200
Last updated 2019-11-18
Summary
The relationship between immune inflammation-related protein complexes in blood and recurrence or metastasis of breast cancer with completed standard treatment will be studied.
Conditions
Sponsors & Collaborators
-
Peking Union Medical College Hospital
lead OTHER
Principal Investigators
-
Chang Chen · Peking Union Medical College Hospital
Eligibility
- Min Age
- 36 Years
- Max Age
- 60 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2019-04-01
- Primary Completion
- 2020-03-31
- Completion
- 2025-03-31
Countries
- China
Study Locations
More Related Trials
-
The Association Between Plasma Metabolites and the Risk, Efficacy and Prognosis in Early Breast Cancer
NCT06698679 ·Status: RECRUITING
-
Dynamic Monitoring of HER2 and ctDNA Specific Mutations in Patients With Recurrent or Metastatic Breast Cancer by Digital PCR
NCT03947736 ·Status: UNKNOWN
-
A Study for Dynamic Prediction Model of Breast Cancer Bone Metastases
NCT06544668 ·Status: NOT_YET_RECRUITING
-
Using a Blood Test to Monitor Metastatic Breast Cancer Treatment
NCT05804578 ·Status: RECRUITING
-
Circulating Tumor Cell Detection in Patients With Luminal A Breast Cancer
NCT04065321 ·Status: RECRUITING
-
Prognostic Value of Biomarkers in HR + / HER2 - Advanced Breast Cancer
NCT04683770 ·Status: UNKNOWN
-
Gut Microbiome Components Predict Response to Neoadjuvant Therapy in HER2-positive Breast Cancer Patients : A Prospective Study
NCT05444647 ·Status: UNKNOWN
-
Gene Expression Profiling of Metastatic Breast Cancer Predict the Therapeutic Response to Chemotherapy
NCT01198301 ·Status: COMPLETED
-
Artificial Intelligence Analysis for Magnetic Resonance Imaging in Screening and Diagnosis of Breast Cancer
NCT05243121 ·Status: UNKNOWN
-
Rapid Assessment of Sentinel Lymph Node Metastasis Status Using a Pan-CK-targeting NIR-II Fluorescent Probe in Breast Cancer
NCT07154563 ·Status: RECRUITING
-
Patterns of Breast Cancer Management and Prognosis of Breast Cancer in China
NCT04076111 ·Status: NOT_YET_RECRUITING
-
Artificial Intelligence Analysis for Magnetic Resonance Imaging in Screening Breast Cancer in High-risk Women
NCT04996615 ·Status: UNKNOWN
-
Miti-gene Recurrence Score in HR+/HER2- Chinese Breast Cancer Patients
NCT07052734 ·Status: COMPLETED
-
Prediction of Non-sentinel Lymph Node Metastatic Status of Breast Cancer Based on Pathology-MRI Images
NCT06510738 ·Status: NOT_YET_RECRUITING
-
Sentinel Lymph Node Biopsy in Clinically Node-negative Early Breast Cancer Patients After Neoadjuvant Chemotherapy
NCT03381092 ·Status: UNKNOWN
-
Genes That Affect Disease Progression in Women With Newly Diagnosed or Metastatic Breast Cancer
NCT00463034 ·Status: UNKNOWN
-
Development of Multi-specific Antibodies Based on Immune Microenvironment of Breast Cancer
NCT05767931 ·Status: UNKNOWN
-
Recurrence Risk Evaluation by 21-gene Detection
NCT03841266 ·Status: COMPLETED
-
A Nation-wide Multicenter Clinical Epidemiologic Study of Chinese Females With Advanced Breast
NCT03047889 ·Status: UNKNOWN
-
The Diagnosis and Prognosis of Nonpalpable Breast Cancer Detected by the US vs Mammography: a Clinical Noninferiority Trial.
NCT04360616 ·Status: UNKNOWN
-
Inflammatory Blood Markers in Breast Cancer Patients Receiving Neoadjuvant Chemotherapy
NCT05468710 ·Status: UNKNOWN
-
Exploratory Research on Constructing a Computational Biological Model Based on NGS for MRD After Breast Cancer Surgery
NCT06595966 ·Status: RECRUITING
-
Correlation Between PET/CT Parameters and Tumor Markers in Recurrent Breast Cancer
NCT05064475 ·Status: UNKNOWN
-
Characterizing Breast Cancer With 68Ga-FAPI PET/CT (PFB-01)
NCT05574907 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Artificial Intelligence Analysis of Fluorescence Image to Intraoperatively Detect Metastatic Sentinel Lymph Node.
NCT05623280 ·Status: UNKNOWN